A citation-based method for searching scientific literature

Madhukar H Trivedi, A John Rush, Stephen R Wisniewski, Andrew A Nierenberg, Diane Warden, Louise Ritz, Grayson Norquist, Robert H Howland, Barry Lebowitz, Patrick J McGrath, Kathy Shores-Wilson, Melanie M Biggs, G K Balasubramani, Maurizio Fava. Am J Psychiatry 2006
Times Cited: 2311







List of co-cited articles
466 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.
A John Rush, Madhukar H Trivedi, Stephen R Wisniewski, Andrew A Nierenberg, Jonathan W Stewart, Diane Warden, George Niederehe, Michael E Thase, Philip W Lavori, Barry D Lebowitz,[...]. Am J Psychiatry 2006
26

A rating scale for depression.
M HAMILTON. J Neurol Neurosurg Psychiatry 1960
19

Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
Andrea Cipriani, Toshi A Furukawa, Georgia Salanti, Anna Chaimani, Lauren Z Atkinson, Yusuke Ogawa, Stefan Leucht, Henricus G Ruhe, Erick H Turner, Julian P T Higgins,[...]. Lancet 2018
803
13

The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.
A John Rush, Madhukar H Trivedi, Hicham M Ibrahim, Thomas J Carmody, Bruce Arnow, Daniel N Klein, John C Markowitz, Philip T Ninan, Susan Kornstein, Rachel Manber,[...]. Biol Psychiatry 2003
10

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Carlos A Zarate, Jaskaran B Singh, Paul J Carlson, Nancy E Brutsche, Rezvan Ameli, David A Luckenbaugh, Dennis S Charney, Husseini K Manji. Arch Gen Psychiatry 2006
9


Antidepressant effects of ketamine in depressed patients.
R M Berman, A Cappiello, A Anand, D A Oren, G R Heninger, D S Charney, J H Krystal. Biol Psychiatry 2000
8

Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants.
Ronald S Duman, George K Aghajanian, Gerard Sanacora, John H Krystal. Nat Med 2016
565
8

The economic burden of adults with major depressive disorder in the United States (2005 and 2010).
Paul E Greenberg, Andree-Anne Fournier, Tammy Sisitsky, Crystal T Pike, Ronald C Kessler. J Clin Psychiatry 2015
734
8

The molecular neurobiology of depression.
Vaishnav Krishnan, Eric J Nestler. Nature 2008
7

Depression.
Gin S Malhi, J John Mann. Lancet 2018
448
7

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists.
Nanxin Li, Boyoung Lee, Rong-Jian Liu, Mounira Banasr, Jason M Dwyer, Masaaki Iwata, Xiao-Yuan Li, George Aghajanian, Ronald S Duman. Science 2010
6

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments.
Sidney H Kennedy, Raymond W Lam, Roger S McIntyre, S Valérie Tourjman, Venkat Bhat, Pierre Blier, Mehrul Hasnain, Fabrice Jollant, Anthony J Levitt, Glenda M MacQueen,[...]. Can J Psychiatry 2016
353
6

Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.
Ronald C Kessler, Patricia Berglund, Olga Demler, Robert Jin, Kathleen R Merikangas, Ellen E Walters. Arch Gen Psychiatry 2005
5

Decreased expression of synapse-related genes and loss of synapses in major depressive disorder.
Hyo Jung Kang, Bhavya Voleti, Tibor Hajszan, Grazyna Rajkowska, Craig A Stockmeier, Pawel Licznerski, Ashley Lepack, Mahesh S Majik, Lak Shin Jeong, Mounira Banasr,[...]. Nat Med 2012
381
5

Cross-trial prediction of treatment outcome in depression: a machine learning approach.
Adam Mourad Chekroud, Ryan Joseph Zotti, Zarrar Shehzad, Ralitza Gueorguieva, Marcia K Johnson, Madhukar H Trivedi, Tyrone D Cannon, John Harrison Krystal, Philip Robert Corlett. Lancet Psychiatry 2016
223
5

Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.
A John Rush, Madhukar H Trivedi, Stephen R Wisniewski, Jonathan W Stewart, Andrew A Nierenberg, Michael E Thase, Louise Ritz, Melanie M Biggs, Diane Warden, James F Luther,[...]. N Engl J Med 2006
691
5

A new depression scale designed to be sensitive to change.
S A Montgomery, M Asberg. Br J Psychiatry 1979
5

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).
Ronald C Kessler, Patricia Berglund, Olga Demler, Robert Jin, Doreen Koretz, Kathleen R Merikangas, A John Rush, Ellen E Walters, Philip S Wang. JAMA 2003
5

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.
D V Sheehan, Y Lecrubier, K H Sheehan, P Amorim, J Janavs, E Weiller, T Hergueta, R Baker, G C Dunbar. J Clin Psychiatry 1998
5

The GABAergic deficit hypothesis of major depressive disorder.
B Luscher, Q Shen, N Sahir. Mol Psychiatry 2011
405
5

Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants.
Luca Santarelli, Michael Saxe, Cornelius Gross, Alexandre Surget, Fortunato Battaglia, Stephanie Dulawa, Noelia Weisstaub, James Lee, Ronald Duman, Ottavio Arancio,[...]. Science 2003
5

Stress, depression, and neuroplasticity: a convergence of mechanisms.
Christopher Pittenger, Ronald S Duman. Neuropsychopharmacology 2008
5


NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses.
Anita E Autry, Megumi Adachi, Elena Nosyreva, Elisa S Na, Maarten F Los, Peng-fei Cheng, Ege T Kavalali, Lisa M Monteggia. Nature 2011
4

How do antidepressants work? New perspectives for refining future treatment approaches.
Catherine J Harmer, Ronald S Duman, Philip J Cowen. Lancet Psychiatry 2017
150
4

Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.
Harvey A Whiteford, Louisa Degenhardt, Jürgen Rehm, Amanda J Baxter, Alize J Ferrari, Holly E Erskine, Fiona J Charlson, Rosana E Norman, Abraham D Flaxman, Nicole Johns,[...]. Lancet 2013
4

Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression.
Naomi R Wray, Stephan Ripke, Manuel Mattheisen, Maciej Trzaskowski, Enda M Byrne, Abdel Abdellaoui, Mark J Adams, Esben Agerbo, Tracy M Air, Till M F Andlauer,[...]. Nat Genet 2018
865
4

Contribution of common genetic variants to antidepressant response.
Katherine E Tansey, Michel Guipponi, Xiaolan Hu, Enrico Domenici, Glyn Lewis, Alain Malafosse, Jens R Wendland, Cathryn M Lewis, Peter McGuffin, Rudolf Uher. Biol Psychiatry 2013
114
4

Using Measurement-Based Care to Enhance Any Treatment.
Kelli Scott, Cara C Lewis. Cogn Behav Pract 2015
122
4

A Tipping Point for Measurement-Based Care.
John C Fortney, Jürgen Unützer, Glenda Wrenn, Jeffrey M Pyne, G Richard Smith, Michael Schoenbaum, Henry T Harbin. Psychiatr Serv 2017
142
4

The Hamilton Depression Rating Scale: has the gold standard become a lead weight?
R Michael Bagby, Andrew G Ryder, Deborah R Schuller, Margarita B Marshall. Am J Psychiatry 2004
579
4



Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression.
Denis J David, Benjamin Adam Samuels, Quentin Rainer, Jing-Wen Wang, Douglas Marsteller, Indira Mendez, Michael Drew, Douglas A Craig, Bruno P Guiard, Jean-Philippe Guilloux,[...]. Neuron 2009
808
4

The sequenced treatment alternatives to relieve depression (STAR*D) trial: a review.
Mark Sinyor, Ayal Schaffer, Anthony Levitt. Can J Psychiatry 2010
140
4

A brief measure for assessing generalized anxiety disorder: the GAD-7.
Robert L Spitzer, Kurt Kroenke, Janet B W Williams, Bernd Löwe. Arch Intern Med 2006
4

Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design.
A John Rush, Maurizio Fava, Stephen R Wisniewski, Philip W Lavori, Madhukar H Trivedi, Harold A Sackeim, Michael E Thase, Andrew A Nierenberg, Frederic M Quitkin, T Michael Kashner,[...]. Control Clin Trials 2004
623
4

Signaling pathways underlying the rapid antidepressant actions of ketamine.
Ronald S Duman, Nanxin Li, Rong-Jian Liu, Vanja Duric, George Aghajanian. Neuropharmacology 2012
333
4

Gender differences in treatment response to sertraline versus imipramine in chronic depression.
S G Kornstein, A F Schatzberg, M E Thase, K A Yonkers, J P McCullough, G I Keitner, A J Gelenberg, S M Davis, W M Harrison, M B Keller. Am J Psychiatry 2000
427
3


A molecular signature of depression in the amygdala.
Etienne Sibille, Yingjie Wang, Jennifer Joeyen-Waldorf, Chris Gaiteri, Alexandre Surget, Sunghee Oh, Catherine Belzung, George C Tseng, David A Lewis. Am J Psychiatry 2009
127
3

Linking molecules to mood: new insight into the biology of depression.
Vaishnav Krishnan, Eric J Nestler. Am J Psychiatry 2010
403
3

A negative regulator of MAP kinase causes depressive behavior.
Vanja Duric, Mounira Banasr, Pawel Licznerski, Heath D Schmidt, Craig A Stockmeier, Arthur A Simen, Samuel S Newton, Ronald S Duman. Nat Med 2010
278
3

R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects.
C Yang, Y Shirayama, J-c Zhang, Q Ren, W Yao, M Ma, C Dong, K Hashimoto. Transl Psychiatry 2015
267
3

NMDAR inhibition-independent antidepressant actions of ketamine metabolites.
Panos Zanos, Ruin Moaddel, Patrick J Morris, Polymnia Georgiou, Jonathan Fischell, Greg I Elmer, Manickavasagom Alkondon, Peixiong Yuan, Heather J Pribut, Nagendra S Singh,[...]. Nature 2016
715
3

The antidepressant fluoxetine restores plasticity in the adult visual cortex.
José Fernando Maya Vetencourt, Alessandro Sale, Alessandro Viegi, Laura Baroncelli, Roberto De Pasquale, Olivia F O'Leary, Eero Castrén, Lamberto Maffei. Science 2008
581
3

BDNF release is required for the behavioral actions of ketamine.
Ashley E Lepack, Manabu Fuchikami, Jason M Dwyer, Mounira Banasr, Ronald S Duman. Int J Neuropsychopharmacol 2014
197
3

NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL/6J mice.
Adam K Walker, David P Budac, Stephanie Bisulco, Anna W Lee, Robin A Smith, Brent Beenders, Keith W Kelley, Robert Dantzer. Neuropsychopharmacology 2013
248
3

Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
M Bryant Howren, Donald M Lamkin, Jerry Suls. Psychosom Med 2009
3


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.